D.SAP, an apple-based formulation could treat SARS-CoV-2 infection, and reduce associated inflammatory responses in COVID-19 infected mice model
Abstract Introduction: The SARS-CoV-2 virus is a virus that may cause severe respiratory disorders with an unclear rate of death. Natural vinegar may have an immune-boosting quality that effectively fights influenza-like respiratory infections. We aimed to evaluate the role of a specially formulated Iranian apple vinegar called Dezhakam sap (D.SAP) in the mice model of covid-19 in the treatment of infection and reduction of covid19-associated lung inflammation. Methods: We designed a covid-19-positive model of male inbred BALB/c mice by viral exposure. Then all mice were examined for active SARS-CoV-2 infection. Mice with positive covid-19 infection were separated into different groups to study the effect of treatment by different concentrations of D.SAP smoke for seven days. Expression assessments for viral RNA on covid-19 affected mice models for three SARS-CoV-2 genes (RDRP, N, and E) and three inflammation markers (IL6, IL1b, and TNF) in lung tissue of all mice were assessed using Real-time PCR. Results: Results showed a significant decrease in viral load in the RDRP gene, N gene, and E gene in all infected rats treated with D.SAP compared with off-treatment mice. In addition, all three inflammation factor genes in infected mice that were treated with D.SAP were significantly reduced compared to the off-treatment infected mice. Conclusion: Findings showed the effectiveness of specially formulated apple vinegar D.SAP to attack new coronavirus. In addition, results may suggest the effectiveness of D.SAP to reduce the lethal inflammation in COVID-19 infection with low side effects. Anti-inflammatory agents block certain substances in the body that cause inflammation. D.SAP may consider a potential natural anti-inflammatory that may increase the survival rate of COVID-19 infection. It seems these effects could be related to the antimicrobial and antioxidant effects of D.SAP due to its polyphenolic compounds..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
ResearchSquare.com - (2022) vom: 23. Aug. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dezhakam, Hossein [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.21203/rs.3.rs-1983034/v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XRA036987530 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XRA036987530 | ||
| 003 | DE-627 | ||
| 005 | 20230429192441.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220827s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21203/rs.3.rs-1983034/v1 |2 doi | |
| 035 | |a (DE-627)XRA036987530 | ||
| 035 | |a (ResearchSquare)10.21203/rs.3.rs-1983034/v1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dezhakam, Hossein |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a D.SAP, an apple-based formulation could treat SARS-CoV-2 infection, and reduce associated inflammatory responses in COVID-19 infected mice model |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Introduction: The SARS-CoV-2 virus is a virus that may cause severe respiratory disorders with an unclear rate of death. Natural vinegar may have an immune-boosting quality that effectively fights influenza-like respiratory infections. We aimed to evaluate the role of a specially formulated Iranian apple vinegar called Dezhakam sap (D.SAP) in the mice model of covid-19 in the treatment of infection and reduction of covid19-associated lung inflammation. Methods: We designed a covid-19-positive model of male inbred BALB/c mice by viral exposure. Then all mice were examined for active SARS-CoV-2 infection. Mice with positive covid-19 infection were separated into different groups to study the effect of treatment by different concentrations of D.SAP smoke for seven days. Expression assessments for viral RNA on covid-19 affected mice models for three SARS-CoV-2 genes (RDRP, N, and E) and three inflammation markers (IL6, IL1b, and TNF) in lung tissue of all mice were assessed using Real-time PCR. Results: Results showed a significant decrease in viral load in the RDRP gene, N gene, and E gene in all infected rats treated with D.SAP compared with off-treatment mice. In addition, all three inflammation factor genes in infected mice that were treated with D.SAP were significantly reduced compared to the off-treatment infected mice. Conclusion: Findings showed the effectiveness of specially formulated apple vinegar D.SAP to attack new coronavirus. In addition, results may suggest the effectiveness of D.SAP to reduce the lethal inflammation in COVID-19 infection with low side effects. Anti-inflammatory agents block certain substances in the body that cause inflammation. D.SAP may consider a potential natural anti-inflammatory that may increase the survival rate of COVID-19 infection. It seems these effects could be related to the antimicrobial and antioxidant effects of D.SAP due to its polyphenolic compounds. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Dezhakam, Amin |e verfasserin |4 aut | |
| 700 | 1 | |a Dezhakam, Ani |e verfasserin |4 aut | |
| 700 | 1 | |a Haghighatfard, Arvin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2022) vom: 23. Aug. |
| 773 | 1 | 8 | |g year:2022 |g day:23 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-1983034/v1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XRA | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 23 |c 08 | ||